Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
The Journal of Infectious Diseases|November 14, 1997
BOX-polymerase chain reaction-based DNA analysis of nonserotypeable Streptococcus pneumoniae implicated in outbreaks of conjunctivitisN Ertugrul, M C Rodriguez-Barradas, D M Musher, et al.
Gut|July 17, 2003
Mortality in Barrett's oesophagus: results from a population based studyL A Anderson, L J Murray, S J Murphy, et al.
Human Molecular Genetics|August 15, 2006
Aberrant cortical synaptic plasticity and dopaminergic dysfunction in a mouse model of Huntington's diseaseDamian M Cummings, Austen J Milnerwood, Glenn M Dallérac, et al.
Human Molecular Genetics|April 8, 2006
Early development of aberrant synaptic plasticity in a mouse model of Huntington's diseaseAusten J Milnerwood, Damian M Cummings, Glenn M Dallérac, et al.
Psycho-Oncology|May 13, 2008
Oesophageal cancer: caregiver mental health and strainM Donnelly, L A Anderson, B T Johnston, et al.
The European Journal of Neuroscience|December 8, 2004
Autonomous activity of CaMKII is only transiently increased following the induction of long-term potentiation in the rat hippocampusI Lengyel, K Voss, M Cammarota, et al.
Neuro-Degenerative Diseases|February 2, 2011
Impaired long-term potentiation in the prefrontal cortex of Huntington's disease mouse models: rescue by D1 dopamine receptor activationG M Dallérac, S C Vatsavayai, D M Cummings, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2016
Chromoplectic TPM3-ALK rearrangement in a patient with inflammatory myofibroblastic tumor who responded to ceritinib after progression on crizotinibA S Mansfield, S J Murphy, F R Harris, et al.
Neuro-Degenerative Diseases|April 15, 2015
Dysfunctional Dopaminergic Neurones in Mouse Models of Huntington's Disease: A Role for SK3 ChannelsGlenn M Dallérac, Grégoire Levasseur, Sarat C Vatsavayai, et al.
Pageof 9